Royalty Pharma Plc (RPRX)
58.31
-0.74
(-1.25%)
USD |
NASDAQ |
Sep 15, 15:20
Royalty Pharma Market Cap : 25.99B for Sept. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 14, 2026 | 26.32B |
| September 11, 2026 | 26.13B |
| September 10, 2026 | 26.19B |
| September 09, 2026 | 27.01B |
| September 08, 2026 | 27.01B |
| September 04, 2026 | 28.51B |
| September 03, 2026 | 28.47B |
| September 02, 2026 | 28.13B |
| September 01, 2026 | 27.78B |
| August 31, 2026 | 27.37B |
| August 28, 2026 | 27.12B |
| August 27, 2026 | 27.60B |
| August 26, 2026 | 27.55B |
| August 25, 2026 | 27.67B |
| August 24, 2026 | 27.34B |
| August 21, 2026 | 27.33B |
| August 20, 2026 | 27.00B |
| August 19, 2026 | 27.52B |
| August 18, 2026 | 26.61B |
| August 17, 2026 | 26.50B |
| August 14, 2026 | 26.12B |
| August 13, 2026 | 26.10B |
| August 12, 2026 | 26.40B |
| August 11, 2026 | 25.76B |
| August 10, 2026 | 25.84B |
| Date | Value |
|---|---|
| August 07, 2026 | 25.30B |
| August 06, 2026 | 25.52B |
| August 05, 2026 | 25.74B |
| August 04, 2026 | 25.62B |
| August 03, 2026 | 25.48B |
| July 31, 2026 | 26.04B |
| July 30, 2026 | 26.31B |
| July 29, 2026 | 26.38B |
| July 28, 2026 | 26.73B |
| July 27, 2026 | 26.18B |
| July 24, 2026 | 26.22B |
| July 23, 2026 | 26.31B |
| July 22, 2026 | 26.17B |
| July 21, 2026 | 26.04B |
| July 20, 2026 | 25.54B |
| July 17, 2026 | 25.93B |
| July 16, 2026 | 26.09B |
| July 15, 2026 | 25.10B |
| July 14, 2026 | 24.81B |
| July 13, 2026 | 25.16B |
| July 10, 2026 | 25.15B |
| July 09, 2026 | 25.84B |
| July 08, 2026 | 26.02B |
| July 07, 2026 | 25.76B |
| July 06, 2026 | 25.37B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 505.04B |
| Johnson & Johnson | 640.30B |
| Merck & Co., Inc. | 355.02B |
| Viatris, Inc. | 19.20B |
| ANI Pharmaceuticals, Inc. | 1.639B |
Market Cap Related Metrics
| PE Ratio | 31.04 |
| PS Ratio | 12.08 |
| Price to Book Value | 3.804 |
| Price to Free Cash Flow | 50.03 |
| Price | 58.31 |
| Earnings Yield | 3.22% |
| Operating PE Ratio | 19.38 |
| Normalized PE Ratio | 33.01 |